Abstract：【Objective】 To explore the influencing factors of myasthenia gravis crisis (POMC) after thymectomy in children with myasthenia gravis (MG). 【Methods】 A total of 78 children with MG who underwent thymectomy were admitted to our hospital,of which 28 had POMC (POMC group) and 50 did not(the non POMC group). The influencing factors of POMC after thymectomy in MG patients were analyzed. 【Results】 Univariate analysis showed that the duration of MG in the POMC group and the non POMC group was (34.0 ± 4.8) months and (11.0 ± 1.4) months,respectively,with a statistically significant difference between the two groups (P<0.05); In the POMC group,there were 2 cases (7.1%),21 cases (75.0%),4 cases (14.3%),and 1 case (3.6%) of modified Osserman classification Ⅱa,Ⅱb,Ⅲ,and Ⅳ,respectively. In the non POMC group,there were 15 cases (30.0%),32 cases (64.0%),3 cases (6.0%),and 0 cases,respectively,with statistically significant differences (P<0.05); In the POMC group,18 cases (64.3%) underwent video-assisted thoracoscopic surgery and 10 cases (35.7%) underwent traditional open surgery,respectively. There was a statistically significant difference compared to 45 cases (90.0%) and 5 cases (10.0%) in the non POMC group (P<0.05); There were 13 cases (46.4%) and 0 cases of postoperative pneumonia in the POMC group and the non POMC group,respectively,with a statistically significant difference between the two groups (P<0.05). The statistically significant factors in univariate analysis were used as independent variables,and the occurrence of POMC in MG patients was included as the dependent variable in logistic regression analysis. The results suggest that the course of MG and postoperative pneumonia are independent risk factors for POMC in MG patients (P<0.05),while the surgical method (video-assisted thoracoscopic surgery) is a protective factor (P<0.05). 【Conclusion】 The occurrence of POMC in pediatric MG patients after thymectomy is closely related to the course of preoperative MG and postoperative pneumonia; Compared to traditional open surgery,video-assisted thoracoscopic surgery can significantly avoid the occurrence of POMC and is worthy of clinical promotion.
张思思, 王军, 张昆. 儿童重症肌无力患者胸腺切除术后肌无力危象的影响因素[J]. 医学临床研究, 2023, 40(4): 508-510.
ZHANG Si-si, WANG Jun, ZHANG Kun. Factors Affecting Myasthenia Gravis Crisis after Thymectomy in Children with Myasthenia Gravis. JOURNAL OF CLINICAL RESEARCH, 2023, 40(4): 508-510.
[1] FANG W.Hospital and healthcare insurance system record-based epidemiological study of myasthenia gravis in southern and northern China[J].Neurol Sci,2020,41(5):1211-1223. [2] MOURI H,JO T,MATSUI H,et al. Effect of sugammadex on postoperative myasthenic crisis in myasthenia gravis patients:propensity score analysis of a Japanese Nationwide Database[J].Anesth Analg,2020,130(2):367-373. [3] LI Y,WANG H,CHEN P,et al. Clinical outcome and predictive factors of postoperative myasthenic crisis in 173 thymomatous myasthenia gravis patients[J].Int J Neurosci,2018,128(2):103-109. [4] HUANG Y,SU L,ZHANG Y,et al. Risk factors for postoperative myasthenic crisis after thymectomy in patients with myasthenia gravis[J].J Surg Res,2021,262:1-5. [5] QI K.Video-assisted thoracoscopic surgery thymectomy versus open thymectomy in patients with myasthenia gravis:a meta-analysis[J].Acta Chir Belg,2016,116(5):282-288. [6] 中国免疫学会神经免疫分会. 中国重症肌无力诊断和治疗指南(2020版)[J].中国神经免疫学和神经病学杂志,2021,28(1):1-12. [7] QIU Z.Perioperative outcomes and mid-term effects in performing video-assisted thoracoscopic extended thymectomy for myasthenia gravis:subxiphoid versus right thoracic approaches[J].J Thorac Dis,2020,12(4):1529-1539. [8] KHARLAMOVA A D,LUSHCHEKINA S V,PETROV K A,et al. Slow-binding inhibition of acetylcholinesterase by an alkylammonium derivative of 6-methyluracil:mechanism and possible advantages for myasthenia gravis treatment[J].Biochem J,2016,473(9):1225-1236. [9] MCHARDY S F,WANG H L,MCCOWEN S V,et al. Recent advances in acetylcholinesterase inhibitors and reactivators:an update on the patent literature (2012-2015)[J].Expert Opin Ther Pat,2017,27(4):455-476. [10] LORENZONI P J,KAY C S K,DUCCI R D,et al. Celebrating the 70 years of pyridostigmine on therapy of myasthenia gravis:historical aspects of the preliminary trials[J].Arq Neuropsiquiatr,2020,78(3):179-181. [11] WANG M G,HUANNG X X,YAO D,et al. Effect of glucocorticoid combined with gamma globulin in treatment of children with myasthenia gravis and its effects on immune globulin and complement of children[J].Eur Rev Med Pharmacol Sci,2016,20(11):2404-2408. [12] CHU X Y,XUE Z Q,WANGANG R W,et al. Predictors of postoperative myasthenic crisis in patients with myasthenia gravis after thymectomy[J].Chin Med J (Engl),2011,124(8):1246-1250. [13] XUE L,WANG L,DONG J,et al. Risk factors of myasthenic crisis after thymectomy for thymoma patients with myasthenia gravis[J].Eur J Cardiothorac Surg,2017,52(4):692-697.
2023, Vol. 40 
